Mahasin Mujahid

Mahasin Mujahid


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2011 in American Journal of Hypertension
Verified
Journal Article
Open access
PDF file
MMMahasin Mujahid
Mahasin Mujahid
ARAna V. Diez Roux
Ana V. Diez Roux
RCRichard C. Cooper
Richard C. Cooper
SSSteven Shea
Steven Shea
DWDavid R. Williams
David R. Williams
Background. The reasons for racial/ethnic disparities in hypertension (HTN) prevalence in the United States are poorly understood.Methods. Using data from the M

13 December 2021 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
MMMahasin Mujahid
Mahasin Mujahid
XGXing Gao
Xing Gao
LTLoni P. Tabb
Loni P. Tabb
CMColleen Morris
Colleen Morris
TLTené T. Lewis
Tené T. Lewis
We investigated historical redlining, a government-sanctioned discriminatory policy, in relation to cardiovascular health (CVH) and whether associations were modified by present-day neighborhood physical and social environments. Data included 4,779 participants (mean age 62 y; SD = 10) from the baseline sample of the Multi-Ethnic Study of Atherosclerosis (MESA; 2000 to 2002). Ideal CVH was a summary measure of ideal levels of seven CVH risk factors based on established criteria (blood pressure, fasting glucose, cholesterol, body mass index, diet, physical activity, and smoking). We assigned MESA participants’ neighborhoods to one of four grades (A: best, B: still desirable, C: declining, and D: hazardous) using the 1930s federal Home Owners’ Loan Corporation (HOLC) maps, which guided decisions regarding mortgage financing. Two-level hierarchical linear and logistic models, with a random intercept to account for participants nested within neighborhoods (i.e., census tracts) were used to assess associations within racial/ethnic subgroups (non-Hispanic White, non-Hispanic Black, Hispanic, and non-Hispanic Chinese). We found that Black adults who lived in historically redlined areas had a 0.82 (95% CI −1.54, −0.10) lower CVH score compared to those residing in grade A (best) neighborhoods, in a given neighborhood and adjusting for confounders. We also found that as the current neighborhood social environment improved the association between HOLC score and ideal CVH weakened (P < 0.10). There were no associations between HOLC grade and CVH measures or effect modification by current neighborhood conditions for any other racial/ethnic group. Results suggest that historical redlining has an enduring impact on cardiovascular risk among Black adults in the United States. Significance How structural racism contributes to the disproportionate burden of cardiovascular disease risk on minoritized groups in the United States is understudied. This study examined the impact of historical redlining, a government-sanctioned and racially discriminatory policy, and present-day cardiovascular health (CVH). Results suggested that living in historically redlined neighborhoods was associated with CVH only among Black participants and that within this group, living in a neighborhood with better social environment quality weakened but did not fully attenuate this association. These findings suggest that, similar to the institution of slavery, redlining is one manifestation of structural racism that drives health outcomes today. This work underscores the necessity to investigate structural racism as a root cause of racial/ethnic health inequities.


1 March 2017 in Health & Place
Verified
Journal Article
Closed access
MMMahasin Mujahid
Mahasin Mujahid
LMLatetia V. Moore
Latetia V. Moore
LPLucia C. Petito
Lucia C. Petito
Kiarri KershawKiarri Kershaw
Kiarri Kershaw
KWKarol Watson
Karol Watson
ARAna V. Diez Roux
Ana V. Diez Roux

9 October 2010 in Journal of Cancer Survivorship
Verified
Journal Article
Open access
PDF file
MMMahasin Mujahid
Mahasin Mujahid
NJNancy K. Janz
Nancy K. Janz
SHSarah T. Hawley
Sarah T. Hawley
JGJennifer J. Griggs
Jennifer J. Griggs
AHAnn S. Hamilton
Ann S. Hamilton
SKSteven J. Katz
Steven J. Katz
Introduction We examined race/ethnic differences in treatment-related job loss and the financial impact of treatment-related job loss, in a population-based sample of women diagnosed with breast cancer. Methods Three thousand two hundred fifty two women with non-metastatic breast cancer diagnosed (August 2005–February 2007) within the Los Angeles County and Detroit Metropolitan Surveillance Epidemiology and End Results registries, were identified and asked to complete a survey (mean time from diagnosis = 8.9 months). Latina and African American women were over-sampled (n = 2268, eligible response rate 72.1%). Results One thousand one hundred eleven women (69.6%) of working age (<65 years) were working for pay at time of diagnosis. Of these women, 10.4% (24.1% Latina, 10.1% African American, 6.9% White, p < 0.001) reported that they lost or quit their job since diagnosis due to breast cancer or its treatment (defined as job loss). Latina women were more likely to experience job loss compared to White women (OR = 2.0, p = 0.013)), independent of sociodemographic factors. There were no significant differences in job loss between African American and White women, independent of sociodemographic factors. Additional adjustments for clinical and treatment factors revealed a significant interaction between race/ethnicity and chemotherapy (p = 0.007). Among women who received chemotherapy, Latina women were more likely to lose their job compared to White women (OR = 3.2, p < 0.001), however, there were no significant differences between Latina and White women among those who did not receive chemotherapy. Women who lost their job were more likely to experience financial strain (e.g. difficulty paying bills 27% vs. 11%, p < 0.001). Conclusion Job loss is a serious consequence of treatment for women with breast cancer. Clinicians and staff need to be aware of aspects of treatment course that place women at higher risk for job loss, especially ethnic minorities receiving chemotherapy.

23 February 2021 in Circulation
Verified
Journal Article
Closed access
PDF file
DGDavid Calvin Goff
David Calvin Goff
SKSadiya Sana Khan
Sadiya Sana Khan
DLDonald M Lloyd-Jones
Donald M Lloyd-Jones
DADonna K. Arnett
Donna K. Arnett
MCMercedes R Carnethon
Mercedes R Carnethon
JWJanet S. Wright
Janet S. Wright
More than 40 years after the 1978 Bethesda Conference on the Declining Mortality from Coronary Heart Disease provided the scientific community with a blueprint for systematic analysis to understand declining rates of coronary heart disease, there are indications the decline has ended or even reversed despite advances in our knowledge about the condition and treatment. Recent data show a more complex situation, with mortality rates for overall cardiovascular disease, including coronary heart disease and stroke, decelerating, whereas those for heart failure are increasing. To mark the 40th anniversary of the Bethesda Conference, the National Heart, Lung, and Blood Institute and the American Heart Association cosponsored the “Bending the Curve in Cardiovascular Disease Mortality: Bethesda + 40” symposium. The objective was to examine the immediate and long-term outcomes of the 1978 conference and understand the current environment. Symposium themes included trends and future projections in cardiovascular disease (in the United States and internationally), the evolving obesity and diabetes epidemics, and harnessing emerging and innovative opportunities to preserve and promote cardiovascular health and prevent cardiovascular disease. In addition, participant-led discussion explored the challenges and barriers in promoting cardiovascular health across the lifespan and established a potential framework for observational research and interventions that would begin in early childhood (or ideally in utero). This report summarizes the relevant research, policy, and practice opportunities discussed at the symposium.